A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Summary

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

Timeline

Start

2020-12-18

Primary completion

2026-06

Completion

2027-04

Outcome

Met primary endpoint

release “primary endpoint was met in the VISTAS Phase 2b study evaluating volixibat” mirumpharma.com ↗

Drugs

Indications